Result of AGM

    RNS Number : 4915I
  Henderson Morley PLC
  19 November 2008
   
    19 NOVEMBER 2008

    HENDERSON MORLEY PLC
    (AIM: HML)

    RESULT OF AGM 


    The Board of Henderson Morley plc ("Henderson Morley" or "the Company"), the AIM quoted biotechnology company, announces that at the
Company's Annual General Meeting held earlier today, all the resolutions were duly passed.

    ---ENDS---


    ENQUIRIES:

    HENDERSON MORLEY PLC                                                   0121 442 4600
    Andrew Knight, Chairman            

    BISHOPSGATE COMMUNICATIONS LTD                                 0207 562 3350
    Maxine Barnes
    Nick Rome

    BREWIN DOLPHIN INVESTMENT BANKING                             0113 241 0126
    Neil Baldwin

    HYBRIDAN LLP                                                                   0203 159 5085
    Claire Noyce/Stephen Austin    

    Further information on Henderson Morley plc can be accessed through the Company's website at www.henderson-morley.com 


    Notes to Editors:

    Henderson Morley was founded in 1996 with the objective of developing its anti viral application (Ionic Contra Viral Therapy (ICVT).
ICVT is the Lead Platform and has been developed in-house and HML wholly owns the patent IPR. 












































This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RAGFFSFEUSASELF

Henderson Mrly. (LSE:HML)
過去株価チャート
から 6 2024 まで 7 2024